Identification of Drug Combination Therapies for SARS-CoV-2: A Molecular Dynamics Simulations Approach

PURPOSE: The development of effective treatments for coronavirus infectious disease 19 (COVID-19) caused by SARS-Coronavirus-2 was hindered by the little data available about this virus at the start of the pandemic. Drug repurposing provides a good strategy to explore approved drugs’ possible SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Halim, Heba, Hajar, Malak, Hasouneh, Luma, Abdelmalek, Suzanne M A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469804/
https://www.ncbi.nlm.nih.gov/pubmed/36110398
http://dx.doi.org/10.2147/DDDT.S366423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469804/
https://www.ncbi.nlm.nih.gov/pubmed/36110398
http://dx.doi.org/10.2147/DDDT.S366423

Ejemplares similares